BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 16116434)

  • 1. The vertebrate Hef ortholog is a component of the Fanconi anemia tumor-suppressor pathway.
    Mosedale G; Niedzwiedz W; Alpi A; Perrina F; Pereira-Leal JB; Johnson M; Langevin F; Pace P; Patel KJ
    Nat Struct Mol Biol; 2005 Sep; 12(9):763-71. PubMed ID: 16116434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3R coordination by Fanconi anemia proteins.
    Macé G; Bogliolo M; Guervilly JH; Dugas du Villard JA; Rosselli F
    Biochimie; 2005 Jul; 87(7):647-58. PubMed ID: 15935541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.
    Hussain S; Witt E; Huber PA; Medhurst AL; Ashworth A; Mathew CG
    Hum Mol Genet; 2003 Oct; 12(19):2503-10. PubMed ID: 12915460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia.
    Levran O; Attwooll C; Henry RT; Milton KL; Neveling K; Rio P; Batish SD; Kalb R; Velleuer E; Barral S; Ott J; Petrini J; Schindler D; Hanenberg H; Auerbach AD
    Nat Genet; 2005 Sep; 37(9):931-3. PubMed ID: 16116424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How Fanconi anemia proteins promote the four Rs: replication, recombination, repair, and recovery.
    Thompson LH; Hinz JM; Yamada NA; Jones NJ
    Environ Mol Mutagen; 2005; 45(2-3):128-42. PubMed ID: 15668941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FANCE: the link between Fanconi anaemia complex assembly and activity.
    Pace P; Johnson M; Tan WM; Mosedale G; Sng C; Hoatlin M; de Winter J; Joenje H; Gergely F; Patel KJ
    EMBO J; 2002 Jul; 21(13):3414-23. PubMed ID: 12093742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interplay of Fanconi anemia proteins in the DNA damage response.
    Wang X; D'Andrea AD
    DNA Repair (Amst); 2004; 3(8-9):1063-9. PubMed ID: 15279794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The genetic and molecular basis of Fanconi anemia.
    de Winter JP; Joenje H
    Mutat Res; 2009 Jul; 668(1-2):11-9. PubMed ID: 19061902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Dub"bing a tumor suppressor pathway.
    Niedzwiedz W; Patel KJ
    Cancer Cell; 2005 Feb; 7(2):114-5. PubMed ID: 15710323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular basis of Fanconi's anemia].
    Digweed M
    Klin Padiatr; 1999; 211(4):192-7. PubMed ID: 10472548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fanconi anemia C gene product plays a role in the fidelity of blunt DNA end-joining.
    Escarceller M; Buchwald M; Singleton BK; Jeggo PA; Jackson SP; Moustacchi E; Papadopoulo D
    J Mol Biol; 1998 Jun; 279(2):375-85. PubMed ID: 9642044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant Fanconi anaemia protein profiles in acute myeloid leukaemia cells.
    Xie Y; de Winter JP; Waisfisz Q; Nieuwint AW; Scheper RJ; Arwert F; Hoatlin ME; Ossenkoppele GJ; Schuurhuis GJ; Joenje H
    Br J Haematol; 2000 Dec; 111(4):1057-64. PubMed ID: 11167740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human MutS and FANCM complexes function as redundant DNA damage sensors in the Fanconi Anemia pathway.
    Huang M; Kennedy R; Ali AM; Moreau LA; Meetei AR; D'Andrea AD; Chen CC
    DNA Repair (Amst); 2011 Dec; 10(12):1203-12. PubMed ID: 21975120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Fanconi anemia pathway: insights from somatic cell genetics using DT40 cell line.
    Takata M; Ishiai M; Kitao H
    Mutat Res; 2009 Jul; 668(1-2):92-102. PubMed ID: 19622405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemosensitizing tumor cells by targeting the Fanconi anemia pathway with an adenovirus overexpressing dominant-negative FANCA.
    Ferrer M; de Winter JP; Mastenbroek DC; Curiel DT; Gerritsen WR; Giaccone G; Kruyt FA
    Cancer Gene Ther; 2004 Aug; 11(8):539-46. PubMed ID: 15192709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular biology of Fanconi anaemia--an old problem, a new insight.
    Ahmad SI; Hanaoka F; Kirk SH
    Bioessays; 2002 May; 24(5):439-48. PubMed ID: 12001267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A human ortholog of archaeal DNA repair protein Hef is defective in Fanconi anemia complementation group M.
    Meetei AR; Medhurst AL; Ling C; Xue Y; Singh TR; Bier P; Steltenpool J; Stone S; Dokal I; Mathew CG; Hoatlin M; Joenje H; de Winter JP; Wang W
    Nat Genet; 2005 Sep; 37(9):958-63. PubMed ID: 16116422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in protein expression due to deleterious mutations in the FA/BRCA pathway.
    Salles D; Cabral RE; Pizzatti L; Bisch PM; Paixão JC; de Almeida CE; Seuánez HN; Cabral-Neto JB
    Biochem Biophys Res Commun; 2007 Dec; 364(4):755-60. PubMed ID: 17977515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of TP53 associated genes in Fanconi anemia cells after mitomycin C and hydroxyurea treatment.
    Martinez A; Hinz JM; Gómez L; Molina B; Acuña H; Jones IM; Frias S; Coleman MA
    Mutat Res; 2008 Oct; 656(1-2):1-7. PubMed ID: 18647660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stabilizing and remodeling the blocked DNA replication fork: anchoring FANCM and the Fanconi anemia damage response.
    Thompson LH; Jones NJ
    Mol Cell; 2010 Mar; 37(6):749-51. PubMed ID: 20347418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.